A study from Vanderbilt-Ingram Cancer Center and the Department of Veterans Affairs led by Anna Vilgelm, MD, Ph.D., and Ann Richmond, Ph.D., has identified a possible second-line treatment for melanoma patients.
Aug 15, 2019
0
32
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer. The National Cancer Institute estimates more than 96,000 new cases will be diagnosed this year, ...
Aug 2, 2019
0
3
Researchers at Tel Aviv University, led by Prof. Carmit Levy and Dr. Tamar Golan of the Department of Human Genetics and Biochemistry at TAU's Sackler School of Medicine, have discovered that fat cells are involved in the ...
Jul 24, 2019
0
574
Being able to identify targets for adoptive cell therapies is one of the first steps in developing personalized treatments for people with hard-to-treat cancers. However, predicting whether a patient will have an immune response ...
Jul 22, 2019
0
1
Uveal melanoma is a very aggressive type of melanoma that affects the eye. It is a rare disorder, affecting an estimated 2,500 people in the United States each year. However, nearly half of uveal melanoma patients will develop ...
Jul 8, 2019
0
916
(HealthDay)—Patients with multiple primary melanomas have worse overall survival than those with a single primary melanoma, according to a study published online June 26 in JAMA Dermatology.
Jul 1, 2019
0
0
Primary care physicians trained in dermatoscopy can improve odds for early detection of melanoma while reducing the need for invasive biopsies, according to a study in The Journal of the American Osteopathic Association.
Jul 1, 2019
0
0
Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden's most common ...
Jul 1, 2019
0
1
Walter and Eliza Hall Institute researchers have used computational biology to discover a "gene signature" that identifies a group of melanoma patients with improved rates of survival.
Jun 25, 2019
0
0
Researchers at Oregon State University and Oregon Health & Science University have found a possible counterpunch to the drug resistance of melanoma, the most dangerous form of skin cancer.
Jun 18, 2019
0
8
